What is AnaptysBio (ANAB)?
AnaptysBio is a biotechnology company engaged in the discovery and development of antibody therapeutics for the treatment of inflammatory diseases and cancer. The company utilizes its proprietary antibody discovery platform to generate novel antibodies with enhanced therapeutic properties. Its research focuses on immunology and oncology, aiming to address unmet medical needs through innovative biologic therapies. AnaptysBio collaborates with pharmaceutical partners and conducts clinical trials to evaluate the safety and efficacy of its product candidates. The company operates within the biopharmaceutical industry, contributing to advancements in targeted treatments.
AnaptysBio Stock Price Today: Live Overview
The price today is shaped by current trading conditions, as AnaptysBio trades at $65.02. Its level has varied between $62.81 and $65.94 with a daily percentage change of 0%.
FAQ: AnaptysBio (ANAB)
What is the current price of ANAB stock?
The last traded price is $65.02.
Does ANAB pay dividends?
AnaptysBio does not pay dividends.
Does ANAB have a formal corporate presence or regional headquarters in the UAE?
AnaptysBio does not maintain a regional office or subsidiary in the UAE and operates via distributors.
What is ANAB best known for?
AnaptysBio is most famous for developing antibody therapeutics for inflammation and immuno-oncology.
What assets are typically shown together with ANAB?
Commonly shown alongside ANAB: Ituran Location and Control Ltd, Editas Medicine, Polynovo Limited
Latest shares articles



